nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Naltrexone—alcohol dependence	0.234	0.602	CbGbCtD
Carfilzomib—ABCB1—Citalopram—alcohol dependence	0.155	0.398	CbGbCtD
Carfilzomib—Chest wall pain—Citalopram—alcohol dependence	0.0185	0.0609	CcSEcCtD
Carfilzomib—Neuritis—Disulfiram—alcohol dependence	0.0153	0.0505	CcSEcCtD
Carfilzomib—Hepatic failure—Disulfiram—alcohol dependence	0.00924	0.0304	CcSEcCtD
Carfilzomib—Pulmonary hypertension—Citalopram—alcohol dependence	0.00907	0.0299	CcSEcCtD
Carfilzomib—PSMB10—digestive system—alcohol dependence	0.00901	0.0342	CbGeAlD
Carfilzomib—Musculoskeletal chest pain—Citalopram—alcohol dependence	0.00872	0.0287	CcSEcCtD
Carfilzomib—PSMB10—blood—alcohol dependence	0.00859	0.0325	CbGeAlD
Carfilzomib—PSMB8—adrenal cortex—alcohol dependence	0.00767	0.0291	CbGeAlD
Carfilzomib—PSMB10—endocrine gland—alcohol dependence	0.00745	0.0282	CbGeAlD
Carfilzomib—Bacterial infection—Citalopram—alcohol dependence	0.00732	0.0241	CcSEcCtD
Carfilzomib—PSMB10—testis—alcohol dependence	0.0071	0.0269	CbGeAlD
Carfilzomib—PSMB10—nervous system—alcohol dependence	0.00697	0.0264	CbGeAlD
Carfilzomib—PSMB8—pancreas—alcohol dependence	0.0068	0.0258	CbGeAlD
Carfilzomib—PSMB5—adrenal cortex—alcohol dependence	0.00677	0.0257	CbGeAlD
Carfilzomib—PSMB10—liver—alcohol dependence	0.00671	0.0255	CbGeAlD
Carfilzomib—PSMB10—central nervous system—alcohol dependence	0.00671	0.0254	CbGeAlD
Carfilzomib—Lymphopenia—Citalopram—alcohol dependence	0.0066	0.0217	CcSEcCtD
Carfilzomib—PSMB10—cerebellum—alcohol dependence	0.00656	0.0249	CbGeAlD
Carfilzomib—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00628	0.0207	CcSEcCtD
Carfilzomib—PSMB2—forebrain—alcohol dependence	0.00623	0.0236	CbGeAlD
Carfilzomib—PSMB5—pancreas—alcohol dependence	0.00601	0.0228	CbGeAlD
Carfilzomib—PSMB1—adrenal cortex—alcohol dependence	0.00592	0.0224	CbGeAlD
Carfilzomib—PSMB2—adrenal cortex—alcohol dependence	0.00577	0.0219	CbGeAlD
Carfilzomib—Hypoaesthesia—Disulfiram—alcohol dependence	0.00572	0.0188	CcSEcCtD
Carfilzomib—PSMB8—blood—alcohol dependence	0.00553	0.021	CbGeAlD
Carfilzomib—PSMB1—cardiovascular system—alcohol dependence	0.0054	0.0205	CbGeAlD
Carfilzomib—PSMB10—brain—alcohol dependence	0.00533	0.0202	CbGeAlD
Carfilzomib—PSMB2—cardiovascular system—alcohol dependence	0.00527	0.02	CbGeAlD
Carfilzomib—PSMB1—pancreas—alcohol dependence	0.00525	0.0199	CbGeAlD
Carfilzomib—PSMB2—pancreas—alcohol dependence	0.00512	0.0194	CbGeAlD
Carfilzomib—PSMB1—gonad—alcohol dependence	0.0049	0.0186	CbGeAlD
Carfilzomib—PSMB5—blood—alcohol dependence	0.00489	0.0185	CbGeAlD
Carfilzomib—PSMB5—midbrain—alcohol dependence	0.00483	0.0183	CbGeAlD
Carfilzomib—PSMB2—gonad—alcohol dependence	0.00478	0.0181	CbGeAlD
Carfilzomib—PSMB8—testis—alcohol dependence	0.00458	0.0173	CbGeAlD
Carfilzomib—PSMB1—digestive system—alcohol dependence	0.00448	0.017	CbGeAlD
Carfilzomib—Renal failure acute—Acamprosate—alcohol dependence	0.00443	0.0146	CcSEcCtD
Carfilzomib—PSMB2—digestive system—alcohol dependence	0.00437	0.0166	CbGeAlD
Carfilzomib—PSMB8—liver—alcohol dependence	0.00433	0.0164	CbGeAlD
Carfilzomib—PSMB1—blood—alcohol dependence	0.00427	0.0162	CbGeAlD
Carfilzomib—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00427	0.0141	CcSEcCtD
Carfilzomib—PSMB1—midbrain—alcohol dependence	0.00422	0.016	CbGeAlD
Carfilzomib—Myocardial ischaemia—Citalopram—alcohol dependence	0.0042	0.0138	CcSEcCtD
Carfilzomib—PSMB2—blood—alcohol dependence	0.00417	0.0158	CbGeAlD
Carfilzomib—PSMB2—midbrain—alcohol dependence	0.00412	0.0156	CbGeAlD
Carfilzomib—Hyponatraemia—Acamprosate—alcohol dependence	0.00411	0.0135	CcSEcCtD
Carfilzomib—PSMB5—testis—alcohol dependence	0.00404	0.0153	CbGeAlD
Carfilzomib—Ritonavir—CYP2E1—alcohol dependence	0.00388	1	CrCbGaD
Carfilzomib—Pain in extremity—Naltrexone—alcohol dependence	0.00387	0.0127	CcSEcCtD
Carfilzomib—Blood creatinine increased—Acamprosate—alcohol dependence	0.00383	0.0126	CcSEcCtD
Carfilzomib—PSMB5—liver—alcohol dependence	0.00382	0.0145	CbGeAlD
Carfilzomib—PSMB5—cerebellum—alcohol dependence	0.00373	0.0142	CbGeAlD
Carfilzomib—PSMB1—endocrine gland—alcohol dependence	0.0037	0.014	CbGeAlD
Carfilzomib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00369	0.0121	CcSEcCtD
Carfilzomib—PSMB2—endocrine gland—alcohol dependence	0.00361	0.0137	CbGeAlD
Carfilzomib—PSMB1—testis—alcohol dependence	0.00353	0.0134	CbGeAlD
Carfilzomib—Fatigue—Disulfiram—alcohol dependence	0.00352	0.0116	CcSEcCtD
Carfilzomib—Pain—Disulfiram—alcohol dependence	0.00349	0.0115	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00349	0.0115	CcSEcCtD
Carfilzomib—PSMB1—nervous system—alcohol dependence	0.00347	0.0131	CbGeAlD
Carfilzomib—PSMB2—testis—alcohol dependence	0.00345	0.0131	CbGeAlD
Carfilzomib—PSMB8—brain—alcohol dependence	0.00343	0.013	CbGeAlD
Carfilzomib—PSMB2—nervous system—alcohol dependence	0.00338	0.0128	CbGeAlD
Carfilzomib—PSMB1—liver—alcohol dependence	0.00334	0.0127	CbGeAlD
Carfilzomib—PSMB1—central nervous system—alcohol dependence	0.00334	0.0127	CbGeAlD
Carfilzomib—PSMB1—cerebellum—alcohol dependence	0.00326	0.0124	CbGeAlD
Carfilzomib—PSMB2—liver—alcohol dependence	0.00326	0.0124	CbGeAlD
Carfilzomib—PSMB2—central nervous system—alcohol dependence	0.00326	0.0123	CbGeAlD
Carfilzomib—Hyperglycaemia—Acamprosate—alcohol dependence	0.00319	0.0105	CcSEcCtD
Carfilzomib—PSMB2—cerebellum—alcohol dependence	0.00318	0.0121	CbGeAlD
Carfilzomib—Pneumonia—Acamprosate—alcohol dependence	0.00317	0.0104	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00311	0.0102	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00311	0.0102	CcSEcCtD
Carfilzomib—PSMB5—brain—alcohol dependence	0.00303	0.0115	CbGeAlD
Carfilzomib—Pneumonia—Naltrexone—alcohol dependence	0.003	0.00988	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00294	0.00968	CcSEcCtD
Carfilzomib—Sepsis—Citalopram—alcohol dependence	0.00293	0.00965	CcSEcCtD
Carfilzomib—Asthenia—Disulfiram—alcohol dependence	0.00293	0.00964	CcSEcCtD
Carfilzomib—Hypoaesthesia—Acamprosate—alcohol dependence	0.00282	0.00927	CcSEcCtD
Carfilzomib—Oedema peripheral—Acamprosate—alcohol dependence	0.00279	0.00918	CcSEcCtD
Carfilzomib—Hepatic failure—Citalopram—alcohol dependence	0.00273	0.00898	CcSEcCtD
Carfilzomib—Dizziness—Disulfiram—alcohol dependence	0.0027	0.00889	CcSEcCtD
Carfilzomib—Renal failure acute—Citalopram—alcohol dependence	0.00266	0.00875	CcSEcCtD
Carfilzomib—PSMB1—brain—alcohol dependence	0.00265	0.01	CbGeAlD
Carfilzomib—PSMB2—brain—alcohol dependence	0.00259	0.0098	CbGeAlD
Carfilzomib—Headache—Disulfiram—alcohol dependence	0.00256	0.00842	CcSEcCtD
Carfilzomib—Chills—Acamprosate—alcohol dependence	0.00254	0.00836	CcSEcCtD
Carfilzomib—Cardiac disorder—Naltrexone—alcohol dependence	0.00249	0.00818	CcSEcCtD
Carfilzomib—Hyponatraemia—Citalopram—alcohol dependence	0.00246	0.00811	CcSEcCtD
Carfilzomib—Pain in extremity—Citalopram—alcohol dependence	0.00245	0.00807	CcSEcCtD
Carfilzomib—Chills—Naltrexone—alcohol dependence	0.0024	0.00791	CcSEcCtD
Carfilzomib—Back pain—Acamprosate—alcohol dependence	0.00238	0.00785	CcSEcCtD
Carfilzomib—Muscle spasms—Acamprosate—alcohol dependence	0.00237	0.0078	CcSEcCtD
Carfilzomib—Cardiac arrest—Citalopram—alcohol dependence	0.00233	0.00768	CcSEcCtD
Carfilzomib—Anaemia—Acamprosate—alcohol dependence	0.00228	0.0075	CcSEcCtD
Carfilzomib—Back pain—Naltrexone—alcohol dependence	0.00226	0.00742	CcSEcCtD
Carfilzomib—Muscle spasms—Naltrexone—alcohol dependence	0.00224	0.00738	CcSEcCtD
Carfilzomib—Hypokalaemia—Citalopram—alcohol dependence	0.00223	0.00735	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00221	0.00727	CcSEcCtD
Carfilzomib—Leukopenia—Acamprosate—alcohol dependence	0.00221	0.00726	CcSEcCtD
Carfilzomib—Cough—Acamprosate—alcohol dependence	0.00215	0.00708	CcSEcCtD
Carfilzomib—Hypertension—Acamprosate—alcohol dependence	0.00213	0.007	CcSEcCtD
Carfilzomib—Arthralgia—Acamprosate—alcohol dependence	0.0021	0.00691	CcSEcCtD
Carfilzomib—Cough—Naltrexone—alcohol dependence	0.00203	0.0067	CcSEcCtD
Carfilzomib—Hypertension—Naltrexone—alcohol dependence	0.00201	0.00663	CcSEcCtD
Carfilzomib—Infection—Acamprosate—alcohol dependence	0.002	0.00658	CcSEcCtD
Carfilzomib—Arthralgia—Naltrexone—alcohol dependence	0.00199	0.00653	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00197	0.00649	CcSEcCtD
Carfilzomib—Thrombocytopenia—Acamprosate—alcohol dependence	0.00197	0.00648	CcSEcCtD
Carfilzomib—Anorexia—Acamprosate—alcohol dependence	0.00192	0.00631	CcSEcCtD
Carfilzomib—Hyperglycaemia—Citalopram—alcohol dependence	0.00191	0.0063	CcSEcCtD
Carfilzomib—Pneumonia—Citalopram—alcohol dependence	0.0019	0.00626	CcSEcCtD
Carfilzomib—Infection—Naltrexone—alcohol dependence	0.00189	0.00622	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Citalopram—alcohol dependence	0.00186	0.00613	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Citalopram—alcohol dependence	0.00185	0.0061	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00183	0.00603	CcSEcCtD
Carfilzomib—Insomnia—Acamprosate—alcohol dependence	0.00182	0.00599	CcSEcCtD
Carfilzomib—Anorexia—Naltrexone—alcohol dependence	0.00181	0.00597	CcSEcCtD
Carfilzomib—Dyspnoea—Acamprosate—alcohol dependence	0.00179	0.0059	CcSEcCtD
Carfilzomib—Decreased appetite—Acamprosate—alcohol dependence	0.00175	0.00575	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00173	0.00571	CcSEcCtD
Carfilzomib—Insomnia—Naltrexone—alcohol dependence	0.00172	0.00566	CcSEcCtD
Carfilzomib—Constipation—Acamprosate—alcohol dependence	0.00172	0.00566	CcSEcCtD
Carfilzomib—Pain—Acamprosate—alcohol dependence	0.00172	0.00566	CcSEcCtD
Carfilzomib—Dyspnoea—Naltrexone—alcohol dependence	0.0017	0.00558	CcSEcCtD
Carfilzomib—Hypoaesthesia—Citalopram—alcohol dependence	0.00169	0.00556	CcSEcCtD
Carfilzomib—Oedema peripheral—Citalopram—alcohol dependence	0.00167	0.0055	CcSEcCtD
Carfilzomib—Decreased appetite—Naltrexone—alcohol dependence	0.00165	0.00544	CcSEcCtD
Carfilzomib—Fatigue—Naltrexone—alcohol dependence	0.00164	0.0054	CcSEcCtD
Carfilzomib—Pain—Naltrexone—alcohol dependence	0.00163	0.00536	CcSEcCtD
Carfilzomib—Constipation—Naltrexone—alcohol dependence	0.00163	0.00536	CcSEcCtD
Carfilzomib—Body temperature increased—Acamprosate—alcohol dependence	0.00159	0.00523	CcSEcCtD
Carfilzomib—Cardiac disorder—Citalopram—alcohol dependence	0.00158	0.00518	CcSEcCtD
Carfilzomib—Chills—Citalopram—alcohol dependence	0.00152	0.00501	CcSEcCtD
Carfilzomib—Body temperature increased—Naltrexone—alcohol dependence	0.0015	0.00495	CcSEcCtD
Carfilzomib—Asthenia—Acamprosate—alcohol dependence	0.00144	0.00475	CcSEcCtD
Carfilzomib—Back pain—Citalopram—alcohol dependence	0.00143	0.0047	CcSEcCtD
Carfilzomib—Muscle spasms—Citalopram—alcohol dependence	0.00142	0.00467	CcSEcCtD
Carfilzomib—Diarrhoea—Acamprosate—alcohol dependence	0.00138	0.00453	CcSEcCtD
Carfilzomib—Anaemia—Citalopram—alcohol dependence	0.00137	0.00449	CcSEcCtD
Carfilzomib—Asthenia—Naltrexone—alcohol dependence	0.00137	0.00449	CcSEcCtD
Carfilzomib—Dizziness—Acamprosate—alcohol dependence	0.00133	0.00438	CcSEcCtD
Carfilzomib—Leukopenia—Citalopram—alcohol dependence	0.00132	0.00435	CcSEcCtD
Carfilzomib—Diarrhoea—Naltrexone—alcohol dependence	0.0013	0.00429	CcSEcCtD
Carfilzomib—Cough—Citalopram—alcohol dependence	0.00129	0.00424	CcSEcCtD
Carfilzomib—Vomiting—Acamprosate—alcohol dependence	0.00128	0.00421	CcSEcCtD
Carfilzomib—Hypertension—Citalopram—alcohol dependence	0.00128	0.0042	CcSEcCtD
Carfilzomib—Headache—Acamprosate—alcohol dependence	0.00126	0.00415	CcSEcCtD
Carfilzomib—Dizziness—Naltrexone—alcohol dependence	0.00126	0.00414	CcSEcCtD
Carfilzomib—Arthralgia—Citalopram—alcohol dependence	0.00126	0.00414	CcSEcCtD
Carfilzomib—Vomiting—Naltrexone—alcohol dependence	0.00121	0.00398	CcSEcCtD
Carfilzomib—Infection—Citalopram—alcohol dependence	0.0012	0.00394	CcSEcCtD
Carfilzomib—Nausea—Acamprosate—alcohol dependence	0.00119	0.00393	CcSEcCtD
Carfilzomib—Headache—Naltrexone—alcohol dependence	0.00119	0.00392	CcSEcCtD
Carfilzomib—Thrombocytopenia—Citalopram—alcohol dependence	0.00118	0.00389	CcSEcCtD
Carfilzomib—Anorexia—Citalopram—alcohol dependence	0.00115	0.00378	CcSEcCtD
Carfilzomib—Nausea—Naltrexone—alcohol dependence	0.00113	0.00372	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.0011	0.00362	CcSEcCtD
Carfilzomib—Insomnia—Citalopram—alcohol dependence	0.00109	0.00359	CcSEcCtD
Carfilzomib—Dyspnoea—Citalopram—alcohol dependence	0.00108	0.00354	CcSEcCtD
Carfilzomib—Decreased appetite—Citalopram—alcohol dependence	0.00105	0.00345	CcSEcCtD
Carfilzomib—Fatigue—Citalopram—alcohol dependence	0.00104	0.00342	CcSEcCtD
Carfilzomib—Pain—Citalopram—alcohol dependence	0.00103	0.00339	CcSEcCtD
Carfilzomib—Constipation—Citalopram—alcohol dependence	0.00103	0.00339	CcSEcCtD
Carfilzomib—Body temperature increased—Citalopram—alcohol dependence	0.000953	0.00314	CcSEcCtD
Carfilzomib—ABCB1—forebrain—alcohol dependence	0.000952	0.00361	CbGeAlD
Carfilzomib—ABCB1—adrenal cortex—alcohol dependence	0.000882	0.00334	CbGeAlD
Carfilzomib—Asthenia—Citalopram—alcohol dependence	0.000865	0.00285	CcSEcCtD
Carfilzomib—Diarrhoea—Citalopram—alcohol dependence	0.000825	0.00272	CcSEcCtD
Carfilzomib—ABCB1—cardiovascular system—alcohol dependence	0.000805	0.00305	CbGeAlD
Carfilzomib—Dizziness—Citalopram—alcohol dependence	0.000797	0.00262	CcSEcCtD
Carfilzomib—ABCB1—pancreas—alcohol dependence	0.000783	0.00297	CbGeAlD
Carfilzomib—Vomiting—Citalopram—alcohol dependence	0.000767	0.00252	CcSEcCtD
Carfilzomib—Headache—Citalopram—alcohol dependence	0.000755	0.00249	CcSEcCtD
Carfilzomib—ABCB1—gonad—alcohol dependence	0.000731	0.00277	CbGeAlD
Carfilzomib—Nausea—Citalopram—alcohol dependence	0.000716	0.00236	CcSEcCtD
Carfilzomib—ABCB1—digestive system—alcohol dependence	0.000668	0.00253	CbGeAlD
Carfilzomib—ABCB1—blood—alcohol dependence	0.000637	0.00241	CbGeAlD
Carfilzomib—ABCB1—midbrain—alcohol dependence	0.000629	0.00238	CbGeAlD
Carfilzomib—ABCB1—endocrine gland—alcohol dependence	0.000552	0.00209	CbGeAlD
Carfilzomib—ABCB1—testis—alcohol dependence	0.000527	0.002	CbGeAlD
Carfilzomib—ABCB1—nervous system—alcohol dependence	0.000517	0.00196	CbGeAlD
Carfilzomib—ABCB1—liver—alcohol dependence	0.000498	0.00189	CbGeAlD
Carfilzomib—ABCB1—central nervous system—alcohol dependence	0.000498	0.00189	CbGeAlD
Carfilzomib—ABCB1—cerebellum—alcohol dependence	0.000486	0.00184	CbGeAlD
Carfilzomib—ABCB1—brain—alcohol dependence	0.000395	0.0015	CbGeAlD
Carfilzomib—PSMB8—Immune System—WASF2—alcohol dependence	0.000138	0.00353	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—MAOB—alcohol dependence	0.000137	0.0035	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GGT2—alcohol dependence	0.000137	0.0035	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GGT2—alcohol dependence	0.000137	0.0035	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GGT2—alcohol dependence	0.000137	0.0035	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—MAOB—alcohol dependence	0.000136	0.00349	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GGT2—alcohol dependence	0.000135	0.00345	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—WASF1—alcohol dependence	0.000134	0.00343	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—WASF1—alcohol dependence	0.000134	0.00343	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—WASF1—alcohol dependence	0.000134	0.00343	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—OPRD1—alcohol dependence	0.000134	0.00343	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—OPRD1—alcohol dependence	0.000134	0.00341	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—WASF1—alcohol dependence	0.000132	0.00338	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PDYN—alcohol dependence	0.000129	0.00329	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PDYN—alcohol dependence	0.000128	0.00327	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ADH1B—alcohol dependence	0.000125	0.0032	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ADH1B—alcohol dependence	0.000125	0.0032	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ADH1B—alcohol dependence	0.000125	0.0032	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ADH1B—alcohol dependence	0.000124	0.00316	CbGpPWpGaD
Carfilzomib—PSMB2—TCF dependent signaling in response to WNT—EP300—alcohol dependence	0.000121	0.0031	CbGpPWpGaD
Carfilzomib—PSMB1—TCF dependent signaling in response to WNT—EP300—alcohol dependence	0.000121	0.0031	CbGpPWpGaD
Carfilzomib—PSMB5—TCF dependent signaling in response to WNT—EP300—alcohol dependence	0.000121	0.0031	CbGpPWpGaD
Carfilzomib—PSMB8—TCF dependent signaling in response to WNT—EP300—alcohol dependence	0.00012	0.00306	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—WASF2—alcohol dependence	0.00012	0.00305	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CRHR1—alcohol dependence	0.00012	0.00305	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—WASF2—alcohol dependence	0.000119	0.00304	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CRHR1—alcohol dependence	0.000119	0.00304	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by Wnt—EP300—alcohol dependence	0.000119	0.00303	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—GOT2—alcohol dependence	0.000118	0.00302	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by Wnt—EP300—alcohol dependence	0.000118	0.00302	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—GOT2—alcohol dependence	0.000118	0.00301	CbGpPWpGaD
Carfilzomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—EP300—alcohol dependence	0.000118	0.003	CbGpPWpGaD
Carfilzomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—EP300—alcohol dependence	0.000118	0.003	CbGpPWpGaD
Carfilzomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—EP300—alcohol dependence	0.000118	0.003	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALDH2—alcohol dependence	0.000117	0.00298	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALDH2—alcohol dependence	0.000116	0.00296	CbGpPWpGaD
Carfilzomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—EP300—alcohol dependence	0.000116	0.00296	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—WASF1—alcohol dependence	0.000115	0.00293	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—WASF1—alcohol dependence	0.000114	0.00291	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CHRM2—alcohol dependence	0.000112	0.00287	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CHRM2—alcohol dependence	0.000112	0.00286	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by WNT in cancer—EP300—alcohol dependence	0.000109	0.00279	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by WNT in cancer—EP300—alcohol dependence	0.000109	0.00279	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by WNT in cancer—EP300—alcohol dependence	0.000109	0.00279	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by WNT in cancer—EP300—alcohol dependence	0.000108	0.00275	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MAOB—alcohol dependence	0.000104	0.00265	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MAOB—alcohol dependence	0.000104	0.00265	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MAOB—alcohol dependence	0.000104	0.00265	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—OPRM1—alcohol dependence	0.000103	0.00264	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—OPRM1—alcohol dependence	0.000103	0.00262	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MAOB—alcohol dependence	0.000102	0.00262	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—GOT1—alcohol dependence	0.000102	0.00261	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—GOT1—alcohol dependence	0.000102	0.0026	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—OPRD1—alcohol dependence	0.000102	0.0026	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—OPRD1—alcohol dependence	0.000102	0.0026	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—OPRD1—alcohol dependence	0.000102	0.0026	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—OPRD1—alcohol dependence	0.0001	0.00256	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GOT2—alcohol dependence	9.91e-05	0.00253	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GOT2—alcohol dependence	9.86e-05	0.00252	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PDYN—alcohol dependence	9.75e-05	0.00249	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PDYN—alcohol dependence	9.75e-05	0.00249	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PDYN—alcohol dependence	9.75e-05	0.00249	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PDYN—alcohol dependence	9.61e-05	0.00245	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NPY—alcohol dependence	9.5e-05	0.00243	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NPY—alcohol dependence	9.45e-05	0.00241	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CYP2E1—alcohol dependence	9.32e-05	0.00238	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	9.29e-05	0.00237	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CYP2E1—alcohol dependence	9.27e-05	0.00237	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CRH—alcohol dependence	9.16e-05	0.00234	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HTR1B—alcohol dependence	9.16e-05	0.00234	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HTR1B—alcohol dependence	9.12e-05	0.00233	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CRH—alcohol dependence	9.12e-05	0.00233	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CRHR1—alcohol dependence	9.06e-05	0.00231	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CRHR1—alcohol dependence	9.06e-05	0.00231	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CRHR1—alcohol dependence	9.06e-05	0.00231	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—WASF2—alcohol dependence	9.06e-05	0.00231	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—WASF2—alcohol dependence	9.06e-05	0.00231	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—WASF2—alcohol dependence	9.06e-05	0.00231	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—EP300—alcohol dependence	9e-05	0.0023	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—EP300—alcohol dependence	9e-05	0.0023	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—EP300—alcohol dependence	9e-05	0.0023	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	8.98e-05	0.00229	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—GOT2—alcohol dependence	8.97e-05	0.00229	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—GOT2—alcohol dependence	8.97e-05	0.00229	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—GOT2—alcohol dependence	8.97e-05	0.00229	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CRHR1—alcohol dependence	8.93e-05	0.00228	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—WASF2—alcohol dependence	8.93e-05	0.00228	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—EP300—alcohol dependence	8.87e-05	0.00227	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—GOT2—alcohol dependence	8.84e-05	0.00226	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALDH2—alcohol dependence	8.83e-05	0.00226	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALDH2—alcohol dependence	8.83e-05	0.00226	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALDH2—alcohol dependence	8.83e-05	0.00226	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALDH2—alcohol dependence	8.71e-05	0.00222	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—WASF1—alcohol dependence	8.69e-05	0.00222	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—WASF1—alcohol dependence	8.69e-05	0.00222	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—WASF1—alcohol dependence	8.69e-05	0.00222	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle, Mitotic—EP300—alcohol dependence	8.62e-05	0.0022	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle, Mitotic—EP300—alcohol dependence	8.58e-05	0.00219	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—WASF1—alcohol dependence	8.56e-05	0.00219	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GOT1—alcohol dependence	8.56e-05	0.00219	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GGT1—alcohol dependence	8.56e-05	0.00219	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CHRM2—alcohol dependence	8.52e-05	0.00218	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CHRM2—alcohol dependence	8.52e-05	0.00218	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CHRM2—alcohol dependence	8.52e-05	0.00218	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GOT1—alcohol dependence	8.51e-05	0.00218	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GGT1—alcohol dependence	8.51e-05	0.00218	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CHRM2—alcohol dependence	8.4e-05	0.00215	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—DRD4—alcohol dependence	8.01e-05	0.00205	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—DRD4—alcohol dependence	7.97e-05	0.00204	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—OPRM1—alcohol dependence	7.82e-05	0.002	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—OPRM1—alcohol dependence	7.82e-05	0.002	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—OPRM1—alcohol dependence	7.82e-05	0.002	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—GOT1—alcohol dependence	7.74e-05	0.00198	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—GOT1—alcohol dependence	7.74e-05	0.00198	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—GOT1—alcohol dependence	7.74e-05	0.00198	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—OPRM1—alcohol dependence	7.71e-05	0.00197	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—EP300—alcohol dependence	7.71e-05	0.00197	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—EP300—alcohol dependence	7.67e-05	0.00196	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—MAOA—alcohol dependence	7.67e-05	0.00196	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CNR1—alcohol dependence	7.65e-05	0.00195	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	7.64e-05	0.00195	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—GOT1—alcohol dependence	7.63e-05	0.00195	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—MAOA—alcohol dependence	7.63e-05	0.00195	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CNR1—alcohol dependence	7.61e-05	0.00194	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GOT2—alcohol dependence	7.51e-05	0.00192	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GOT2—alcohol dependence	7.51e-05	0.00192	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GOT2—alcohol dependence	7.51e-05	0.00192	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HTR7—alcohol dependence	7.46e-05	0.00191	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—DRD2—alcohol dependence	7.46e-05	0.00191	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HTR7—alcohol dependence	7.43e-05	0.0019	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—DRD2—alcohol dependence	7.43e-05	0.0019	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GOT2—alcohol dependence	7.41e-05	0.00189	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NPY—alcohol dependence	7.2e-05	0.00184	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NPY—alcohol dependence	7.2e-05	0.00184	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NPY—alcohol dependence	7.2e-05	0.00184	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NPY—alcohol dependence	7.1e-05	0.00181	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP2E1—alcohol dependence	7.06e-05	0.0018	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP2E1—alcohol dependence	7.06e-05	0.0018	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP2E1—alcohol dependence	7.06e-05	0.0018	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADH6—alcohol dependence	7.02e-05	0.00179	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP2E1—alcohol dependence	6.96e-05	0.00178	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR1B—alcohol dependence	6.94e-05	0.00177	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR1B—alcohol dependence	6.94e-05	0.00177	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CRH—alcohol dependence	6.94e-05	0.00177	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CRH—alcohol dependence	6.94e-05	0.00177	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR1B—alcohol dependence	6.94e-05	0.00177	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CRH—alcohol dependence	6.94e-05	0.00177	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CRH—alcohol dependence	6.85e-05	0.00175	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR1B—alcohol dependence	6.85e-05	0.00175	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—EP300—alcohol dependence	6.53e-05	0.00167	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—EP300—alcohol dependence	6.53e-05	0.00167	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—EP300—alcohol dependence	6.53e-05	0.00167	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GGT1—alcohol dependence	6.48e-05	0.00166	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GGT1—alcohol dependence	6.48e-05	0.00166	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GOT1—alcohol dependence	6.48e-05	0.00166	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GOT1—alcohol dependence	6.48e-05	0.00166	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GGT1—alcohol dependence	6.48e-05	0.00166	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GOT1—alcohol dependence	6.48e-05	0.00166	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—EP300—alcohol dependence	6.44e-05	0.00165	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GOT1—alcohol dependence	6.39e-05	0.00163	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GGT1—alcohol dependence	6.39e-05	0.00163	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AVP—alcohol dependence	6.28e-05	0.0016	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AVP—alcohol dependence	6.25e-05	0.0016	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—DRD4—alcohol dependence	6.07e-05	0.00155	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—DRD4—alcohol dependence	6.07e-05	0.00155	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—DRD4—alcohol dependence	6.07e-05	0.00155	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—DRD4—alcohol dependence	5.98e-05	0.00153	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—EP300—alcohol dependence	5.84e-05	0.00149	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—EP300—alcohol dependence	5.84e-05	0.00149	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—EP300—alcohol dependence	5.84e-05	0.00149	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADH1A—alcohol dependence	5.82e-05	0.00149	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MAOA—alcohol dependence	5.81e-05	0.00148	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MAOA—alcohol dependence	5.81e-05	0.00148	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MAOA—alcohol dependence	5.81e-05	0.00148	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CNR1—alcohol dependence	5.8e-05	0.00148	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CNR1—alcohol dependence	5.8e-05	0.00148	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CNR1—alcohol dependence	5.8e-05	0.00148	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—EP300—alcohol dependence	5.76e-05	0.00147	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MAOA—alcohol dependence	5.73e-05	0.00146	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CNR1—alcohol dependence	5.71e-05	0.00146	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR7—alcohol dependence	5.65e-05	0.00144	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—DRD2—alcohol dependence	5.65e-05	0.00144	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—DRD2—alcohol dependence	5.65e-05	0.00144	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—DRD2—alcohol dependence	5.65e-05	0.00144	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR7—alcohol dependence	5.65e-05	0.00144	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR7—alcohol dependence	5.65e-05	0.00144	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—DRD2—alcohol dependence	5.58e-05	0.00142	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR7—alcohol dependence	5.58e-05	0.00142	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—HTR2A—alcohol dependence	5.23e-05	0.00134	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—HTR2A—alcohol dependence	5.2e-05	0.00133	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—POMC—alcohol dependence	4.99e-05	0.00128	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—POMC—alcohol dependence	4.97e-05	0.00127	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADH4—alcohol dependence	4.95e-05	0.00126	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AVP—alcohol dependence	4.76e-05	0.00122	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AVP—alcohol dependence	4.76e-05	0.00122	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AVP—alcohol dependence	4.76e-05	0.00122	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AVP—alcohol dependence	4.69e-05	0.0012	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.32e-05	0.0011	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EP300—alcohol dependence	4.28e-05	0.00109	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EP300—alcohol dependence	4.26e-05	0.00109	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADH7—alcohol dependence	4.21e-05	0.00107	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—POMC—alcohol dependence	4.17e-05	0.00107	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—POMC—alcohol dependence	4.15e-05	0.00106	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGT2—alcohol dependence	4.03e-05	0.00103	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	3.97e-05	0.00101	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—HTR2A—alcohol dependence	3.96e-05	0.00101	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—HTR2A—alcohol dependence	3.96e-05	0.00101	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—HTR2A—alcohol dependence	3.96e-05	0.00101	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EP300—alcohol dependence	3.95e-05	0.00101	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EP300—alcohol dependence	3.93e-05	0.00101	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—HTR2A—alcohol dependence	3.9e-05	0.000998	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—POMC—alcohol dependence	3.78e-05	0.000966	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—POMC—alcohol dependence	3.78e-05	0.000966	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—POMC—alcohol dependence	3.78e-05	0.000966	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—POMC—alcohol dependence	3.73e-05	0.000953	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADH1B—alcohol dependence	3.69e-05	0.000942	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	3.58e-05	0.000913	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—EP300—alcohol dependence	3.31e-05	0.000846	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—EP300—alcohol dependence	3.3e-05	0.000842	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EP300—alcohol dependence	3.25e-05	0.000829	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EP300—alcohol dependence	3.25e-05	0.000829	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EP300—alcohol dependence	3.25e-05	0.000829	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EP300—alcohol dependence	3.2e-05	0.000817	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—alcohol dependence	3.16e-05	0.000808	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—alcohol dependence	3.16e-05	0.000808	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—alcohol dependence	3.16e-05	0.000808	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—alcohol dependence	3.12e-05	0.000797	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOB—alcohol dependence	3.06e-05	0.000781	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EP300—alcohol dependence	3e-05	0.000766	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EP300—alcohol dependence	3e-05	0.000766	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EP300—alcohol dependence	3e-05	0.000766	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EP300—alcohol dependence	2.95e-05	0.000755	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EP300—alcohol dependence	2.77e-05	0.000707	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EP300—alcohol dependence	2.76e-05	0.000704	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDH2—alcohol dependence	2.6e-05	0.000664	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—EP300—alcohol dependence	2.51e-05	0.000641	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—EP300—alcohol dependence	2.51e-05	0.000641	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—EP300—alcohol dependence	2.51e-05	0.000641	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—EP300—alcohol dependence	2.47e-05	0.000632	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT2—alcohol dependence	2.21e-05	0.000565	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EP300—alcohol dependence	2.1e-05	0.000536	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EP300—alcohol dependence	2.1e-05	0.000536	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EP300—alcohol dependence	2.1e-05	0.000536	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.08e-05	0.000531	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EP300—alcohol dependence	2.07e-05	0.000529	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGT1—alcohol dependence	1.91e-05	0.000487	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT1—alcohol dependence	1.91e-05	0.000487	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOA—alcohol dependence	1.71e-05	0.000437	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—alcohol dependence	1.11e-05	0.000284	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—EP300—alcohol dependence	7.38e-06	0.000189	CbGpPWpGaD
